Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2.

Stefanik, Michal; Strakova, Petra; Haviernik, Jan; Miller, Andrew D; Ruzek, Daniel; Eyer, Ludek

Stefanik, Michal; Strakova, Petra; Haviernik, Jan; Miller, Andrew D; Ruzek, Daniel; Eyer, Ludek.

Afiliación

Stefanik M; Department of Virology, Veterinary Research Institute, CZ-62100 Brno, Czech Republic.
Strakova P; Department of Chemistry and Biochemistry, Mendel University in Brno, CZ-61300 Brno, Czech Republic.
Haviernik J; Department of Virology, Veterinary Research Institute, CZ-62100 Brno, Czech Republic.
Miller AD; Department of Virology, Veterinary Research Institute, CZ-62100 Brno, Czech Republic.
Ruzek D; Department of Virology, Veterinary Research Institute, CZ-62100 Brno, Czech Republic.
Eyer L; Department of Chemistry and Biochemistry, Mendel University in Brno, CZ-61300 Brno, Czech Republic.

Microorganisms ; 9(3)2021 Feb 25.

Article en En | MEDLINE | ID: mdl-33668694

Palabras clave

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); antiviral activity; cleistanthin B; cytotoxicity; diphyllin; helioxanthin; vacuolar ATPase blocker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Microorganisms Año: 2021 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google